Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MR Guided Phase II Radiotherapy Dose Escalation in Unresectable Non-metastatic Pancreatic Cancer

NCT01972919 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT01972919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01972919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MR Guided Phase II Radiotherapy Dose Escalation in Unresectable Non-metastatic Pancreatic Cancer
Lead sponsor
Medical College of Wisconsin
Phase
Phase 2
Overall status
Completed
Start date
December 10, 2015
Completion date
June 11, 2026
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

unresectable pancreatic cancer